- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Addressing the Physical, Psychological Complexity of IBD Through Coordinated Care
Eva Szigethy, MD, PhD
Explore how the Specialty Medical Home model transforms care for patients with inflammatory bowel disease (IBD) by integrating mental health support and addressing stigma.
The Specialty Medical Home model is reshaping care for people living with inflammatory bowel disease (IBD). IBD, which includes Crohn disease and ulcerative colitis, is a complex, chronic condition that affects millions of people and requires more than just medical management.
In this episode of Managed Care Cast, the conversation focuses on how patients often face not only debilitating gastrointestinal symptoms but also significant psychological challenges, including anxiety, depression, and the stigma that can come with managing an invisible illness.
Developed and implemented at leading centers including the University of Pittsburgh Medical Center (UPMC), the Cleveland Clinic, and Mount Sinai Hospital, this innovative approach is designed to address both the physical and mental health needs of people with IBD through fully integrated, patient-centered, team-based care. The model combines medical treatment with nutritional counseling and behavioral health services to support patients holistically. At its core is the recognition that gut health and mental health are deeply connected and that improving one requires addressing both.
This work is led by the UPMC Center for High-Value Health Care, which received a Patient-Centered Outcomes Research Institute (PCORI) grant to build and study this coordinated care model. Joining us to discuss the impact are 2 of the leaders behind this effort: Eva Szigethy, MD, PhD, a child and adult psychiatrist specializing in gastropsychiatry, who serves as the clinical lead for the IBD Medical Home at UPMC, and Benjamin Cohen, MD, cosection head and clinical director for IBD at Cleveland Clinic, and a coinvestigator in the PCORI-funded study.
Together, they share how this model reduces stigma, promotes patient engagement, and helps individuals better manage the complexity of IBD, especially as treatment options evolve and access to care becomes more fragmented.
Narration was generated using AI.
Listen above or on one of these podcast services:
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
GLP-1 Receptor Agonists Reduce Adverse Cardiovascular Outcomes, Improve Survival
August 2nd 2025Studies found that glucagon-like peptide-1 (GLP-1) receptor agonists were valuable tools in improving outcomes and survival in those with coronary plaque and after ST-elevation myocardial infarction.
Read More
